Search clinical trials for: Budesonide CFC
Total 2029 results
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedStage II Colon Cancer | Stage III Colon CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingCutaneous T-Cell Lymphoma | Peripheral T-Cell Lymphoma | Mature T-cell Malignancies | Relapsed/ Refractory T-cell MalignanciesUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedHematologic DisorderUnited States
-
AmgenCompletedArthritis, PsoriaticUnited States, Spain, Netherlands, Canada, France, Russian Federation, Belgium, Austria, Germany, Italy, United Kingdom
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
Simcere Pharmaceutical Co., LtdThe Affiliated Changzhou Tumor Hospital of Suzhou UniversityUnknownColorectal NeoplasmsChina
-
Baystate Medical CenterNot yet recruitingAtrial FibrillationUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Melanoma | Advanced Melanoma | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Grade 3a Follicular LymphomaUnited States
-
National Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
Stanford UniversityNational Cancer Institute (NCI)CompletedRecurrent Prostate CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedLiver Metastases | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal CancerUnited States
-
Imperial College LondonRoyal Brompton & Harefield NHS Foundation Trust; St George's, University of... and other collaboratorsRecruitingDilated Cardiomyopathy | Sudden Cardiac Death | Sudden Cardiac Death Due to Cardiac Arrhythmia | Sudden Cardiac Arrest | Arrhythmogenic Right Ventricular Cardiomyopathy | Arrhythmogenic Left Ventricular CardiomyopathyUnited Kingdom
-
Juno Therapeutics, a Subsidiary of CelgeneActive, not recruitingMultiple MyelomaUnited States
-
University of SaskatchewanSaskatoon Health RegionCompletedArthroplasty, Replacement, KneeCanada
-
CelgeneActive, not recruitingSmall Cell Lung CarcinomaFrance, Italy, Spain
-
German Cancer Research CenterUniversity Hospital Freiburg; ABX CRO; Friedrich-Alexander-Universität Erlangen-NürnbergCompletedProstate Cancer | Prostate Cancer Metastatic | High-risk Prostate Cancer | Lymphnode MetastasisAustria, Germany
-
CelgeneTerminatedRenal Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
Bristol-Myers SquibbActive, not recruiting
-
Marshall UniversityRecruitingPregnancy Related | Cardiac Output, Low | Systolic Hypertension | Cardiac Output, High | Diastolic HypertensionUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v7United States
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Celgene CorporationRecruitingMultiple SclerosisUnited States, Spain, Germany, Belgium, France, United Kingdom, Italy
-
Richard W Yee, MDNot yet recruitingDry Eye DiseaseUnited States
-
Icahn School of Medicine at Mount SinaiBristol-Myers Squibb; Multiple Myeloma Research ConsortiumEnrolling by invitation
-
CelgeneActive, not recruiting
-
Celgene CorporationPrologue Research InternationalCompletedOvarian CancerUnited States
-
Northwestern UniversityCompletedPostoperative PainUnited States
-
NovavaxNot yet recruiting
-
Sohag UniversityEnrolling by invitationSystemic Lupus ErythematosusEgypt
-
Janssen Research & Development, LLCCompletedA Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in JapanAttention Deficit Disorder With HyperactivityUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI)CompletedPancreatic NeoplasmsUnited States
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, South Africa
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Stanford UniversityCelgene CorporationTerminatedLeukemia | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)United States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminated
-
Mayo ClinicCompletedAmyloidosisUnited States
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Refractory Multiple Myeloma | DS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGrade 3a Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage III Grade 3 Follicular Lymphoma | Ann Arbor Stage...United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States
-
iTeos Belgium SABristol-Myers Squibb; GlaxoSmithKline; iTeos TherapeuticsTerminatedMultiple MyelomaUnited States, France, Spain, Belgium
-
M.D. Anderson Cancer CenterCelgeneTerminatedMalignant GliomasUnited States
-
Synmosa Biopharma Corp.Completed
-
Washington University School of MedicineCompleted
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI); Celgene CorporationCompletedMultiple MyelomaUnited States
-
Timothy R PetersenWithdrawn
-
University of CalgaryCompletedChronic Sinusitis | Steroids | Endoscopic Sinus Surgery | Post-operative Care | Drug-eluting SpacerCanada
-
National Cancer Institute (NCI)CompletedLung | Breast | Ovarian | Cervical | RenalUnited States